ANI-7
ANI-7 is an activator of aryl hydrocarbon receptor (AhR) pathway. ANI-7 inhibits the growth of multiple cancer cells, and potently and selectively inhibits the growth of MCF-7 breast cancer cells with a GI50 of 0.56 μM. ANI-7 induces CYP1-metabolizing mono-oxygenases by activating AhR pathway, and also induces DNA damage, checkpoint Kinase 2 (Chk2) activation, S-phase cell cycle arrest, and cell death in sensitive breast cancer cell lines[1][2][3].
Product Specifications
CAS Number
[931417-26-4]
Product Name Alternative
Prodigiosine (hydrochloride)
UNSPSC
12352005
Target
Aryl Hydrocarbon Receptor; Checkpoint Kinase (Chk)
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Immunology/Inflammation
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ani-7.html
Concentration
10mM
Purity
99.01
Solubility
DMSO : 20.83 mg/mL (ultrasonic)
Smiles
ClC1=CC(/C(C#N)=C/C2=CC=CN2)=CC=C1Cl
Molecular Formula
C13H8Cl2N2
Molecular Weight
263.12
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-117102/ANI-7-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-117102/ANI-7-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Chk2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Casein Kinase 1 alpha (CSNK1A1) (NM_001892) Human Over-expression Lysate
